Search Results

CorInnova’s presentation will be on Tuesday, Oct. 31, at 9:16 a.m. MST.

Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.

CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has been selected to present at the Society for Thoracic Surgeons (STS) / American Association for Thoracic Surgery (AATS) Tech-Con 2018 event to be held this coming Saturday, Jan. 27, in Fort Lauderdale, Fla.

CorInnova announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic heart device to support heart function.

The competition provided U.S.-based innovators and companies with a better understanding of the opportunities available to companies interested in doing business in China as well as well as direct interface with qualified Chinese partners and investors.

Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA.

Premier Life Science Event Showcases Texas Ecosystem

Pediatric Device Innovation Symposium’s pitch competition to address unmet need for children